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INTRODUCTION:  We  report  the  case  of a  21 year old  female  with  underlying  facial  lipodystrophy  who
presented  with  left  lower  abdominal  pain,  weight  gain  and  altered  bowel  habit.
PRESENTATION OF  CASE:  Subsequent  investigation  showed  a  large  (21  cm  ×  18  cm  × 8  cm)  intraabdominal
mass.  At laparotomy,  it was  completely  excised  and  was  seen  to  arise  from  the  transverse  mesocolon  and
following  histology  revealed  it to  be mesenteric  lipodystrophy.eywords:
esenteric
acial
ipodystrophy
DISCUSSION: Mesenteric  lipodystrophy  is  a rare clinical  entity,  and  part of  a  spectrum  of disorders  of
sclerosing  mesenteritis.  This is the  ﬁrst  reported  case  in  a patient  with  pre-existing  facial  lipodystrophy.
CONCLUSION:  Herein  we describe  a  case  of  mesenteric  lipodystrophy,  discuss  its  management  and  review
of  the literature.
© 2012 Surgical Associates Ltd. Published by Elsevier Ltd. Open access under CC BY-NC-ND license. 
bdominal
ass
. Case
We  report the case of a 21-year old woman who presented to
er GP with an approximate 4 week history of dull left iliac fossa
ain radiating to her back, altered bowel habit and weight gain. The
ain began inconspicuously with no apparent precipitating factors.
t was alleviated by simple analgesia. She noticed she had become
ncreasingly constipated in the preceeding month. There was  no
ssociated nausea, vomiting, menstrual or urinary abnormalities.
f note she had a history of ovarian cysts, and was diagnosed
ith facial lipodystrophy aged 11. This presented with facial wast-
ng and an abnormal distribution of body fat. She was  managed
ithout intervention and discharged from paediatric medical out-
atients aged 16. She smoked 20 cigarettes per day for 3 years,
enied illicit drug use, had a moderate alcohol intake and the only
egular medication she took was the OCP. Her family history was
on-contributary.
On clinical examination she had noticeable facial wasting but
lso had increased fat deposition in abdomen, buttocks and thighs.
here was an indistinct, tender mass on deep palpation of her
bdomen. The rest of her examination was unremarkable, as were
ll her haematological investigations.
An ultrasound scan was  performed showing a 1.2 cm left ovar-
an cyst and an unusual appearance of the soft tissues in the upper
bdomen, with appearances suggesting inﬁltration of omental fat
r a large retroperitoneal lesion. CT scan demonstrated a large, pre-
ominantly fatty mass arising from the retroperitoneum in the right
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Open access under CC BY-anterior pararenal space spanning 21.3 cm × 18.4 cm × 8 cm.  It dis-
placed the right colon and small bowel to the left of the midline. The
mass contained multiple areas of soft tissue attenuation suggestive
of a liposarcoma (Fig. 1).
Due to the lesion’s size and concerning radiographical features, a
decision was  made to excise the mass. At laparotomy, a large fatty
mass arising from the transverse mesocolon displacing the small
bowel to the left was  seen. The mass was encapsulated and did
not invade any of the surrounding structures. Mobilisation of the
mass was straightforward and did not necessitate multi-visceral
resection. The mass was  tethered to the ileo-colic pedicle and in
order to ensure a safe oncologic resection, standard right hemi-
colectomy was  performed (Figs. 2 and 3).
Grossly, the lobulated, well-circumscribed mass was  semi-solid
in consistency, with a bright yellow cut surface. Multiple discrete
ﬁrm nodules were dispersed throughout the specimen, averaging
1.6 cm in maximum diameter. Microscopic examination revealed
a multinodular lesion of fatty tissue, composed predominantly of
benign adipocytes without atypia. The ﬁrm nodules evident focally
within the lesion corresponded to areas of fat necrosis with calci-
ﬁcation, surrounded by a mixed lymphoplasmacytic inﬁltrate with
lipid ﬁlled macrophages, and ﬁbrosis (Fig. 4). The ﬁnal pathological
diagnosis was  mesenteric lipodystrophy.
Clinically, the patient made an uneventful recovery with
restoration of bowel function on the fourth post-operative day. She
was discharged well on the seventh post-operative day.
2.  DiscussionMesenteric lipodystrophy is a rare clinical entity with a con-
fusing nomenclature. It describes an inﬂammatory condition of
the mesenteric fat of the abdomen. Since its ﬁrst description,
NC-ND license. 
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Fig. 1. Computer tomography (coronal view) of a large predominantly fatty mass
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mrising from the right pararenal space, displacing the small bowel infero-laterally to
he left. Multiple areas of high attenuation are noted giving the potential differential
iagnosis  of a liposarcoma.
ariations of the pathological process have been reported under
any names, including but not limited to: sclerosing mesenteritis,
esenteric panniculitis, retractile mesenteritis, isolated lipodys-
rophy, mesenteric lipogranuloma and mesenteric manifestation
f Weber–Christian disease.1 In recent times, a consensus has
merged that the condition may  be sub-typed into one of three
iseases based on the histological ﬁndings. Mesenteric lipodystro-
hy shows replacement of mesenteric fat with foamy macrophages,
s in this case. In mesenteric panniculitis, there is an inﬁltrate of
lasma cells and a few polymorphonuclear leukocytes, foreign-
ody giant cells, and foamy macrophages. And ﬁnally, in retractile
ig. 2. Intra-operative image showing the large mass arising from the transverse
esocolon  (forceps pointing to transverse colon).Fig. 3. Gross image of the excised specimen. Measuring ruler is 15 cm.
mesenteritis, histology shows ﬁbrosis characterised by collagen
deposition.2 However, Emory et al.,3 author of a large series of 42
cases, has proposed that it is a single disease made up of a spec-
trum between the above-named subtypes. This is due to many cases
displaying elements of all 3 pathological ﬁndings. Therefore, he
has proposed the name “sclerosing mesenteritis” as an appropriate
umbrella term.
Presentation varies greatly. It most frequently affects men3–5
with a 2:1 male to female preponderance.5 Age of presenta-
tion ranges from 23 to 87 years with an average age of 60.3 It
may be symptomatic or asymptomatic; in approximately half of
cases, it is an incidental ﬁnding in abdominal surgery.1 Symp-
toms, when present, usually involve abdominal pain.3 This depends
on the subtype, e.g., mesenteric lipodystrophy is often painless,
whereas patients with mesenteric panniculitis will often present
with pain.1 Also, large masses as in this case can cause pain due
to compression. Other symptoms frequently encountered include:
anorexia, abdominal fullness, nausea, pyrexia, and weight loss.6
Symptomatic cases can present insidiously or with acute abdominal
symptoms.7 Inﬂammatory markers are unhelpful in diagnosis.2,8 In
Emory’s series, a history of trauma or surgery was  present in four of
84 patients. The most common site of involvement was the small
bowel mesentery as a single mass (58 of 84) with an average size of
10 cm,  multiple masses (15 of 84), or diffuse mesenteric thickening
Fig. 4. Lipid ﬁlled foamy macrophages – arrows (haematoxylin and eosin).
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11 of 84).3 Sole involvement of the mesocolon (the most common
ite being the rectosigmoid colon) has been found in 20% of cases.9
ther possible sites of involvement include peripancreatic region,
mentum, retroperitoneum or pelvis.4,10
Along with surgery and trauma, other related conditions
nclude: “mesenteric thrombosis, mesenteric arteriopathy, drugs,
hermal or chemical injuries, vasculitis, avitaminosis, autoimmune
isease, retained suture material, pancreatitis, bile or urine leakage,
ypersensitivity reactions, and bacterial infection”.2,9 Recently, a
ase associated with rheumatoid arthritis has been reported.11
here is also a strong link with malignancy.9 To our knowledge
here have been no reported cases of mesenteric lipodystrophy in
 patient with acquired partial lipodystrophy, as in this case.
Diagnosis  is usually only reached by deﬁnitive histological
xamination, however, in some cases imaging can be very useful.
maging appearances will depend on the underlying pathologi-
al process: fat necrosis (Mesenteric Lipodystophy), inﬂammation
Mesenteric Panniculitis) or ﬁbrosis (Retractile Mesenteritis).12 It is
isualised usually as a heterogeneous mass with a large fat compo-
ent and interposed linear bands with soft tissue density in cases
f Mesenteric Panniculitis, or as a homogeneous mass of soft tissue
ensity in cases of Retractile Mesenteritis.7
Treatment also depends on the underlying pathological
rocess.5 With fat necrosis (Mesenteric Lipodystophy), it is rea-
onable to adopt conservative management, as it tends to settle
pontaneously.5 With asymptomatic or incidental masses, obser-
ation is also appropriate.7 In inﬂammatory cases (Mesenteric
anniculitis) or ﬁbrosis (Retractile Mesenteritis), medical anti-
nﬂammatory treatment is advised.5 There is no deﬁnite consensus
n which agent should be used but choices include steroids,
zathioprine13 and cyclophosphamide.14 Généreau et al.15 have
emonstrated effective management with colchicines combined
ith corticosteroid in a series of symptomatic patients. Overall,
urgical treatment should be limited to establishing a diagnosis or
reatment of complications.3,16
Prognosis is good in most cases,3 however, in Akram’s series,
hey commented that 20% of cases are associated with signiﬁcant
orbidity and a chronic debilitating course.
In summary we present a case of mesenteric lipodystrophy
n a young woman presenting with signiﬁcant symptoms sec-
ndary to mass effect, which was successfully managed by surgical
esection. This is a rare condition and this is the ﬁrst reported case
n a patient with pre-existing facial lipodystrophy. A relationship
etween these two processes has not previously been established.
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